Jina Won
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Nasal symbiont Staphylococcus epidermidis restricts influenza A virus replication via the creation of a polyamine-deficient cellular environment.
Journal: Communications biology
Published: August 16, 2023
Correction: Symbiotic microbiome Staphylococcus epidermidis restricts IL-33 production in allergic nasal epithelium via limiting the cellular necroptosis.
Journal: BMC microbiology
Published: June 14, 2023
Symbiotic microbiome Staphylococcus epidermidis restricts IL-33 production in allergic nasal epithelium via limiting the cellular necroptosis.
Journal: BMC microbiology
Published: August 26, 2022
Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage.
Journal: Frontiers in immunology
Published: August 01, 2022
Inhaled delivery of recombinant interferon-lambda restores allergic inflammation after development of asthma by controlling Th2- and Th17-cell-mediated immune responses.
Journal: International immunopharmacology
Published: April 26, 2022
Nasal symbiont Staphylococcus epidermidis restricts the cellular entry of influenza virus into the nasal epithelium.
Journal: NPJ biofilms and microbiomes
Published: July 20, 2021
Symbiotic microbiome Staphylococcus aureus from human nasal mucus modulates IL-33-mediated type 2 immune responses in allergic nasal mucosa.
Journal: BMC microbiology
Published: April 26, 2020
The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium.
Journal: Antiviral research
Published: April 08, 2020
IL-17C Protects Nasal Epithelium from Pseudomonas aeruginosa Infection.
Journal: American journal of respiratory cell and molecular biology
Published: July 19, 2019
Last Updated: 09/26/2026